arrow
E

Emmanuele Venanzi Rullo

University of Messina
H指数:25
被引数:1,987

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People with HIV: Real-World Evidence from the SHINe-SHIC Cohort

在治疗经验丰富的HIV感染者中,从其他方案转换为多拉韦林/拉米夫定/富马酸替诺福韦二吡呋酯后的病毒学、血脂、肾脏和肝脏实验室结局:来自SHINe-SHIC队列的真实世界证据

2026-09-180
OA
Saving Beds and Budgets: Real-World Efficacy, Safety, and Pharmacoeconomics of Long-Acting Lipoglycopeptides (LALs) in a Day Hospital Setting

节省病床和预算:长效脂肽类抗生素(LALs)在日间医院环境中的实际疗效、安全性和药物经济学

2026-07-270
OA
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremia

鲍曼不动杆菌碳青霉烯耐药菌血症的死亡预测因素及治疗效果

2026-03-310
OAAI
Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study

卡博格韦–利匹韦林在PLWH中的疗效与安全性:一项真实世界研究

Viruses
IF3.5
2026-03-030
OAAI
Real-world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram-negative infections: Results from a retrospective study

碳青霉烯类耐药革兰氏阴性菌感染的重症患者中费地科尔(cefiderocol)的疗效与安全性:一项回顾性研究的结果

2025-10-010
OA
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort
2024-10-111
OAAI
Assessing ChatGPT's theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists

评估ChatGPT在细菌感染中的理论知识和规定准确性: 与传染病居民和专家的比较研究

2024-07-128
OAAI
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021
2023-11-050
OA
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)
2022-06-1612
OAAI
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
2022-04-067
OAAI